100 related articles for article (PubMed ID: 26222755)
1. One Size Does Not Fit All: The Public Health Ramifications of Proposed Food and Drug Administration Premarket Review for Extragenital Gonorrhea and Chlamydia Testing.
Bolan RK; Beymer MR
Sex Transm Dis; 2015 Jul; 42(7):403-4. PubMed ID: 26222755
[No Abstract] [Full Text] [Related]
2. Are we missing pharyngeal and rectal infections in women by not testing those who report oral and anal sex?
Shaw SG; Hassan-Ibrahim M; Soni S
Sex Transm Infect; 2013 Aug; 89(5):397. PubMed ID: 23858500
[No Abstract] [Full Text] [Related]
3. Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations--five cities, United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(26):716-9. PubMed ID: 19590491
[TBL] [Abstract][Full Text] [Related]
4. Effect of nucleic acid amplification testing on detection of extragenital gonorrhea and chlamydial infections in men who have sex with men sexually transmitted disease clinic patients.
Barbee LA; Dombrowski JC; Kerani R; Golden MR
Sex Transm Dis; 2014 Mar; 41(3):168-72. PubMed ID: 24521722
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of rectal chlamydia and gonorrhea cases among men who have sex with men after the introduction of nucleic acid amplification test screening at 2 Canadian sexually transmitted infection clinics.
Gratrix J; Singh AE; Bergman J; Egan C; McGinnis J; Drews SJ; Read R
Sex Transm Dis; 2014 Oct; 41(10):589-91. PubMed ID: 25211252
[TBL] [Abstract][Full Text] [Related]
6. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003.
Gunn RA; O'Brien CJ; Lee MA; Gilchick RA
Sex Transm Dis; 2008 Oct; 35(10):845-8. PubMed ID: 18607315
[TBL] [Abstract][Full Text] [Related]
7. The challenges of detecting gonorrhoea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more?
Alexander S
Sex Transm Infect; 2009 Jun; 85(3):159-60. PubMed ID: 19478103
[No Abstract] [Full Text] [Related]
8. Gonorrhoea.
Bignell C; Ison CA; Jungmann E
Sex Transm Infect; 2006 Dec; 82 Suppl 4(Suppl 4):iv6-9. PubMed ID: 17151055
[No Abstract] [Full Text] [Related]
9. Use of NAATs for STD diagnosis of GC and CT in non-FDA -cleared anatomic specimens.
Renault CA; Hall C; Kent CK; Klausner JD
MLO Med Lab Obs; 2006 Jul; 38(7):10, 12-6, 21-2; quiz 24, 27. PubMed ID: 16918168
[No Abstract] [Full Text] [Related]
10. Comparing swabs for diagnosing chlamydia and gonorrhea in women: recent findings.
Stewart CM; Schoeman SA; Wilson JD
J Comp Eff Res; 2013 Sep; 2(5):405-7. PubMed ID: 24236734
[No Abstract] [Full Text] [Related]
11. Gonorrhea and multiple site infection: case report and screening opportunities.
D'Antuono A; Baraldi C; Banzola N; Gaspari V; Filippini A; Patrizi A
G Ital Dermatol Venereol; 2016 Jun; 151(3):292-5. PubMed ID: 27176080
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of extragenital screening for gonorrhea and chlamydia in HIV-infected active duty Air Force members.
Patterson SB; Rivera D; Sunil TS; Okulicz JF
MSMR; 2014 Nov; 21(11):7-9. PubMed ID: 25436876
[TBL] [Abstract][Full Text] [Related]
13. Healthcare provider awareness of the recent FDA approval on first diagnostic tests for extragenital testing for chlamydia and gonorrhea.
Tao G; Gift TL
Prev Med; 2022 Jun; 159():107078. PubMed ID: 35533886
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003.
Kent CK; Chaw JK; Wong W; Liska S; Gibson S; Hubbard G; Klausner JD
Clin Infect Dis; 2005 Jul; 41(1):67-74. PubMed ID: 15937765
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid amplification tests for gonorrhea and chlamydia: practice and applications.
Gaydos CA
Infect Dis Clin North Am; 2005 Jun; 19(2):367-86, ix. PubMed ID: 15963877
[TBL] [Abstract][Full Text] [Related]
16. Positive predictive value of the Becton Dickinson VIPER system and the ProbeTec GC Q x assay, in extracted mode, for detection of Neisseria gonorrhoeae.
Pope CF; Hay P; Alexander S; Capaldi K; Dave J; Sadiq ST; Ison CA; Planche T
Sex Transm Infect; 2010 Nov; 86(6):465-9. PubMed ID: 20940160
[TBL] [Abstract][Full Text] [Related]
17. Urine-based asymptomatic urethral gonorrhea and chlamydia screening and sexual risk-taking behavior in men who have sex with men in greater Boston.
Russell CJ; Golub SA; Cohen DE; Mayer KH
AIDS Patient Care STDS; 2007 Mar; 21(3):205-11. PubMed ID: 17428188
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of self-collected versus clinician-collected swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae pharyngeal infection among men who have sex with men.
Freeman AH; Bernstein KT; Kohn RP; Philip S; Rauch LM; Klausner JD
Sex Transm Dis; 2011 Nov; 38(11):1036-9. PubMed ID: 21992980
[TBL] [Abstract][Full Text] [Related]
19. Questioning the value of screening for gonorrhoea in symptomless heterosexual men.
Evans-Jones J
Int J STD AIDS; 2010 Apr; 21(4):302. PubMed ID: 20378909
[No Abstract] [Full Text] [Related]
20. Molecular tests for detection of the sexually-transmitted pathogens Neisseria gonorrhoeae and Chlamydia trachomatis.
Chapin KC
Med Health R I; 2006 Jun; 89(6):202-4. PubMed ID: 16875007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
